First-pass extracted concept

gas therapy

Candidate: concept label3 source documents7 linked claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Gas therapy in this review is mediated by hydrogen-releasing nanomaterials. The abstract says it scavenges ROS and regulates the inflammatory microenvironment to exert immunomodulatory effects.

Source 1DOIPubMed

Resources required

It requires hydrogen-releasing nanomaterials.

Source 1DOIPubMed

What problem it solves

It addresses oxidative and inflammatory components of RA by ROS scavenging and microenvironment regulation.

Source 1DOIPubMed

Evidence Snippets

Gas therapy, mediated by hydrogen-releasing nanomaterials, exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.
Evidence 1Source 1DOIPubMedprovenance
Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges.
Evidence 2Source 2DOIPubMedprovenance
synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy
Evidence 3Source 3DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1advantage statementsupports2026Source 2DOIPubMed

Gas therapy has demonstrated significant potential for prevention and treatment of biofilm-associated infections because of unique bioactivity, low resistance, and synergy with existing treatments.

Quoted textsource-backed
Due to its unique bioactivity, low resistance, and synergy with existing treatments, gas therapy has demonstrated significant potential in the prevention and treatment of biofilm-associated infections.
Claim 2future directionsupports2026Source 2DOIPubMed

Future development of gas therapy should prioritize integration of nanotechnology and mechanistic studies.

Quoted textsource-backed
Future efforts should prioritize the integration of nanotechnology and mechanistic studies to unlock broader therapeutic utility.
Claim 3limitation statementsupports2026Source 2DOIPubMed

Delivery challenges, need for large-scale efficacy validation, and lack of standardized protocols are barriers to clinical translation of gas therapy.

Quoted textsource-backed
However, overcoming delivery challenges, validating efficacy in large-scale trials, and developing standardized protocols are essential for its clinical translation.
Claim 4mechanismsupports2026Source 1DOIPubMed

Gas therapy mediated by hydrogen-releasing nanomaterials exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.

Quoted textsource-backed
Gas therapy, mediated by hydrogen-releasing nanomaterials, exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.
Claim 5problem statementsupports2026Source 2DOIPubMed

Conventional antibiotic therapies often fail to eradicate biofilms, contributing to persistent infections and clinical challenges.

Quoted textsource-backed
Conventional antibiotic therapies often fail to eradicate biofilms, which can lead to persistent infections and significant clinical challenges.
Claim 6therapeutic potentialsupports2026Source 2DOIPubMed

Gas therapy is presented as an emerging strategy to address biofilm-associated infection challenges.

Quoted textsource-backed
Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges.
Claim 7therapeutic strategysupports2025Source 3DOIPubMed

Micro/nano-motors are described as advantageous for synergistic multimodal tumor therapies including chemodynamic, sonodynamic, photothermal, immunotherapy, photodynamic, and gas therapy.

Quoted textsource-backed
we discuss the therapeutic mechanisms of MNMs within the tumor microenvironment in detail and highlight the advantages of synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy.